3-methoxy-4-hydroxyphenylglycol sulfate
RN given refers to cpd with unspecified locant for sulfate moiety
Also Known As:
3-methoxy-4--hydroxyphenylethyleneglycol sulfate; 3-methoxy-4-hydroxyphenylglycol sulfate conjugate; 4-hydroxy-3-methoxyphenylethylene glycol 4-sulfate; MHPG-SO4
Networked: 6
relevant articles (1 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Related Diseases
1. | Shock
02/01/1989
- " Rats exposed to signalled shock (predictable group) showed significant increases in MHPG-SO4 levels in the first four of these regions, as compared to the nonshocked rats. " 01/01/1986
- " In an FR-3 operant schedule, however, the experimental rats which could control shock by emitting three disk-pulling responses showed significantly higher levels of MHPG-SO4 in most brain regions, as compared to FR-1 experimental rats. " 01/01/1986
- " The MHPG-SO4 levels for the experimental rats did not differ significantly from "non-shock" control rats in most regions. " 01/01/1986
- " In an FR-1 operant schedule, experimental rats which could avoid or escape shock by pulling a disk manipulandum only once showed significantly lower levels of MHPG-SO4 in the hypothalamus, amygdala, thalamus, locus coeruleus (LC) region and cerebral cortex than did yoked rats which received the same amount of shock but could not perform any effective avoidance and/or escape responses. " 02/01/1989
- " After 19 hr in a VT-2.5 min shock session, the rats exposed to unsignalled shock (unpredictable group) showed significantly greater increases in MHPG-SO4 levels in the hypothalamus, amygdala, midbrain, cerebral cortex, thalamus and locus coeruleus, as well as in plasma corticosterone levels. "
|
2. | Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
|
3. | Hypertension (High Blood Pressure)
|
|
Related Drugs and Biologics